Navigation path

Pharmaceuticals - Community Register


List of nationally authorised medicinal products for human use

Mometasone Furoate Sandoz and associated names

Product name: Mometasone Furoate Sandoz and associated names
Also marketed in the EU under the name(s): Fumomo, Mometasona Sandoz, Mometasone Furoato Sandoz, Mometasone Sandoz, Mometasonfuroaat Sandoz, Mometasonfuroat Sandoz, Mometazona furoat Sandoz, Mommox, Nasometin
Active substance: Mometasone
Indication: Mometasone furoate nasal spray is indicated
  • for use in adults and children of 6 years and older to treat the symptoms of seasonal allergic or perennial rhinitis.
  • prophylactic treatment in patients who have a history of moderate to severe symptoms of seasonal allergic rhinitis up to four weeks prior to the anticipated start of the pollen season.
  • for the symptomatic treatment of nasal polyps in adults 18 years of age and older.
Marketing Authorisation Holder: Not applicable

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
9/10/2012 Referral EMEA/H/A-29/1332 (2012)7151 of 8/10/2012